title: Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice.
abstract: Depletion of estrogens and progesterone at menopause has been linked to an increased risk for the development of Alzheimer's disease (AD) in women. A currently controversial literature indicates that although treatment of postmenopausal women with hormone therapy (HT) may reduce the risk of AD, several parameters of HT may limit its potential efficacy and perhaps, even exacerbate AD risk. One such parameter is continuous vs. cyclic delivery of the progestogen component of HT. Recent experimental evidence suggests that continuous progesterone can attenuate neural actions of estradiol (E(2)). In the present study, we compared the effects of continuous and cyclic progesterone treatment in the presence and absence of E(2) in ovariectomized 3xTg-AD mice, a transgenic mouse model of AD. We found that ovariectomy-induced hormone depletion increases AD-like pathology in female 3xTg-AD mice, including accumulation of beta-amyloid, tau hyperphosphorylation, and impaired hippocampal-dependent behavior. E(2) treatment alone prevents the increases in pathology. Continuous progesterone did not affect beta-amyloid levels when delivered alone but blocked the Abeta-lowering action of E(2). In contrast, cyclic progesterone significantly reduced beta-amyloid levels by itself and enhanced rather than inhibited the E(2) effects. These results provide new insight into the neural interactions between E(2) and progesterone that may prove valuable in optimizing HT regimens in postmenopausal women.
authors.affiliation: University of Southern California, 3715 McClintock Avenue, Los Angeles, California 90089-0191. cjpike@usc.edu
authors.forename: Jenna C
authors.initials: JC
authors.lastname: Carroll
authors.forename: Emily R
authors.initials: ER
authors.lastname: Rosario
authors.forename: Angela
authors.initials: A
authors.lastname: Villamagna
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Pike
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D004334:Drug Administration Schedule; D004958:Estradiol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D007150:Immunohistochemistry; D018782:Maze Learning / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010052:Ovariectomy; D010766:Phosphorylation; D011374:Progesterone / Q000008:administration & dosage* / Q000627:therapeutic use*; D016875:tau Proteins / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016875:tau Proteins; D011374:Progesterone; D004958:Estradiol
references.citation: Neurosci Lett. 2002 May 3;323(3):191-4
references.pmid: 11959417
references.citation: Neuroscience. 1999;91(3):1143-53
references.pmid: 10391490
references.citation: Arch Neurol. 1994 Sep;51(9):896-900
references.pmid: 8080389
references.citation: Endocrinology. 2008 May;149(5):2607-11
references.pmid: 18276750
references.citation: J Cereb Blood Flow Metab. 2009 Aug;29(8):1359-72
references.pmid: 19458604
references.citation: Horm Behav. 2003 Nov;44(4):319-26
references.pmid: 14613726
references.citation: Brain Res. 2006 Jul 12;1099(1):206-10
references.pmid: 16793026
references.citation: Curr Pharm Des. 2006;12(6):677-84
references.pmid: 16472157
references.citation: Behav Brain Res. 2009 Jan 23;196(2):254-60
references.pmid: 18926853
references.citation: Neuroreport. 2004 Dec 3;15(17):2659-63
references.pmid: 15570173
references.citation: Scand J Clin Lab Invest. 2008;68(8):814-22
references.pmid: 18821130
references.citation: Exp Neurol. 1994 Sep;129(1):64-9
references.pmid: 7925843
references.citation: Neurobiol Aging. 2001 Jul-Aug;22(4):575-80
references.pmid: 11445258
references.citation: Trends Endocrinol Metab. 2002 Aug;13(6):229-30
references.pmid: 12128278
references.citation: JAMA. 2002 Nov 6;288(17):2123-9
references.pmid: 12413371
references.citation: Neuropsychopharmacology. 2006 Nov;31(11):2405-14
references.pmid: 16482087
references.citation: J Neurosci. 1996 Feb 1;16(3):1049-55
references.pmid: 8558233
references.citation: Int Semin Surg Oncol. 2005 Feb 08;2(1):3
references.pmid: 15701175
references.citation: Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):347-58
references.pmid: 10817919
references.citation: Nat Med. 2006 Apr;12(4):379-80
references.pmid: 16598276
references.citation: Eur J Obstet Gynecol Reprod Biol. 1999 Apr;83(2):207-11
references.pmid: 10391534
references.citation: Exp Neurol. 2005 Jun;193(2):522-30
references.pmid: 15869954
references.citation: Brain Res. 2009 Aug 4;1283:177-85
references.pmid: 19497309
references.citation: Science. 2002 Jul 19;297(5580):353-6
references.pmid: 12130773
references.citation: Neuroscience. 2000;101(4):931-8
references.pmid: 11113342
references.citation: Semin Reprod Med. 2009 May;27(3):283-93
references.pmid: 19401959
references.citation: JAMA. 2002 Nov 6;288(17):2170-2
references.pmid: 12413378
references.citation: Lancet. 1996 Aug 17;348(9025):429-32
references.pmid: 8709781
references.citation: Eur J Neurosci. 2009 Feb;29(3):447-54
references.pmid: 19175406
references.citation: Neurology. 1997 Jun;48(6):1517-21
references.pmid: 9191758
references.citation: Neurology. 1999 Mar 23;52(5):965-70
references.pmid: 10102413
references.citation: JAMA. 2004 Jun 23;291(24):2947-58
references.pmid: 15213206
references.citation: Obstet Gynecol. 1995 Feb;85(2):304-13
references.pmid: 7824251
references.citation: Lancet Neurol. 2005 Mar;4(3):190-4
references.pmid: 15721829
references.citation: Pediatr Rehabil. 2003 Jan-Mar;6(1):13-22
references.pmid: 12745891
references.citation: JAMA. 2003 May 28;289(20):2651-62
references.pmid: 12771112
references.citation: Brain Res. 1997 Feb 21;749(1):143-6
references.pmid: 9070640
references.citation: J Neurosci Res. 2003 Dec 1;74(5):637-43
references.pmid: 14635215
references.citation: J Neurobiol. 2006 Aug;66(9):916-28
references.pmid: 16758493
references.citation: Curr Opin Pharmacol. 2008 Dec;8(6):740-6
references.pmid: 18929681
references.citation: Neurobiol Learn Mem. 2008 Jan;89(1):17-26
references.pmid: 17988898
references.citation: Neurology. 1999 Dec 10;53(9):1992-7
references.pmid: 10599770
references.citation: Neuroscience. 2002;113(4):907-14
references.pmid: 12182896
references.citation: Front Neuroendocrinol. 2008 May;29(2):313-39
references.pmid: 18374402
references.citation: Arch Med Res. 2002 Jan-Feb;33(1):6-14
references.pmid: 11825624
references.citation: CNS Drugs. 2004;18(7):405-22
references.pmid: 15139797
references.citation: Epilepsia. 2004 Dec;45(12):1531-8
references.pmid: 15571511
references.citation: J Neurosci. 2006 Dec 20;26(51):13384-9
references.pmid: 17182789
references.citation: Science. 2003 Nov 14;302(5648):1136-8
references.pmid: 14615508
references.citation: Scand J Clin Lab Invest. 2005;65(8):699-705
references.pmid: 16319044
references.citation: J Comp Neurol. 1993 Oct 8;336(2):293-306
references.pmid: 8245220
references.citation: Age (Dordr). 2009 Jun;31(2):143-53
references.pmid: 19322681
references.citation: JAMA. 1995 Jan 18;273(3):199-208
references.pmid: 7807658
references.citation: Clin Obstet Gynecol. 2008 Sep;51(3):618-26
references.pmid: 18677155
references.citation: Front Neuroendocrinol. 2009 Jul;30(2):239-58
references.pmid: 19427328
references.citation: Obstet Gynecol. 1990 Apr;75(4 Suppl):59S-76S; discussion 81S-83S
references.pmid: 2179792
references.citation: Semin Reprod Med. 2005 May;23(2):172-9
references.pmid: 15852203
references.citation: Neurology. 1992 Jan;42(1):115-9
references.pmid: 1734291
references.citation: JAMA. 2004 Jun 23;291(24):2959-68
references.pmid: 15213207
references.citation: J Neurochem. 2003 Nov;87(4):902-13
references.pmid: 14622121
references.citation: Br J Pharmacol. 1999 Sep;128(2):419-27
references.pmid: 10510453
references.citation: Horm Behav. 2008 Aug;54(3):386-95
references.pmid: 18579142
references.citation: Acta Psychiatr Scand. 1987 Nov;76(5):465-79
references.pmid: 3324647
references.citation: Arch Intern Med. 1996 Oct 28;156(19):2213-7
references.pmid: 8885820
references.citation: Eur J Neurosci. 2006 Jul;24(1):229-42
references.pmid: 16882019
references.citation: Behav Genet. 2007 Jan;37(1):214-22
references.pmid: 17177116
references.citation: J Neuroendocrinol. 2009 Jan;21(1):77-81
references.pmid: 19094096
references.citation: Psychopharmacology (Berl). 2006 Jun;186(3):312-22
references.pmid: 16538472
references.citation: Neuroscience. 2002;115(2):547-58
references.pmid: 12421621
references.citation: J Cardiovasc Transl Res. 2009 Sep;2(3):228-39
references.pmid: 19668346
references.citation: J Neurosci. 2007 Nov 28;27(48):13357-65
references.pmid: 18045930
references.citation: Neuron. 2003 Jul 31;39(3):409-21
references.pmid: 12895417
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:569-91
references.pmid: 11264469